Sponsored Content
Inhaled Insulin for Pediatric Patients Shows Positive Results in Phase 3 Trial
MannKind announced results from the INHALE-1 study that examined Afrezza in children and adolescents with diabetes.
Episode 6: High Risk: Diabetes and COVID-19
In this episode of Over the Counter, 2 experts on diabetes management and care discuss the effect COVID-19 is having on individuals with diabetes and the ways that the health care system is responding.
Examining Impact of Continuous Glucose Monitors on Diabetes | ASHP Midyear
Two posters presented at the meeting looked into the topic CGMs in diabetes care.
Q&A: Pharmacists’ Understanding of CKD Therapies, Adverse Effects | ASHP Midyear
Denise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.
SGLT2 Inhibitors May Have Clinical Benefits For Patients with Diabetes After Myocardial Infarction | ASHP Midyear
Research found that SGLT2 inhibitors were associated with a lower risk of major cardiovascular events or hospitalization for heart failure.
Assessing Improvements to Reduce Insulin-Related Hypoglycemic Events | ASHP Midyear
Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.
